Exosome Component 9 (EXOSC9) (Middle Region) Peptide
-
- Target See all EXOSC9 products
- EXOSC9 (Exosome Component 9 (EXOSC9))
- Protein Region
- Middle Region
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Sequence
- IIAEAEPPSE VVSTPVLWTP GTAQIGEGVE NSWGDLEDSE KEDDEGGGDQ
- Characteristics
- This is a synthetic peptide designed for use in combination with anti- EXOSC9 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
- Application Notes
- Optimal working dilution should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- EXOSC9 (Exosome Component 9 (EXOSC9))
- Synonyms
- scl75 Peptide, im:6909054 Peptide, zgc:101680 Peptide, PM/Scl-75 Peptide, PMSCL1 Peptide, RRP45 Peptide, Rrp45p Peptide, p5 Peptide, p6 Peptide, Pmscl1 Peptide, exosome component 9 L homeolog Peptide, exosome component 9 Peptide, exosc9.L Peptide, exosc9 Peptide, EXOSC9 Peptide, Exosc9 Peptide
- Background
-
This gene encodes a component of the human exosome, a exoribonuclease complex which processes and degrades RNA in the nucleus and cytoplasm. This component may play a role in mRNA degradation and the polymyositis/scleroderma autoantigen complex. Alternative splicing results in multiple transcript variants.
Alias Symbols: p5, p6, RRP45, PMSCL1, Rrp45p, PM/Scl-75
Protein Size: 439 - Gene ID
- 5393
- NCBI Accession
- NM_001034194, NP_001029366
- UniProt
- Q06265
-